311 related articles for article (PubMed ID: 12557142)
1. Peroxisome proliferator-activated receptor gamma ligands suppress colon carcinogenesis induced by azoxymethane in mice.
Osawa E; Nakajima A; Wada K; Ishimine S; Fujisawa N; Kawamori T; Matsuhashi N; Kadowaki T; Ochiai M; Sekihara H; Nakagama H
Gastroenterology; 2003 Feb; 124(2):361-7. PubMed ID: 12557142
[TBL] [Abstract][Full Text] [Related]
2. Chemopreventive effect of peroxisome proliferator-activated receptor gamma on gastric carcinogenesis in mice.
Lu J; Imamura K; Nomura S; Mafune K; Nakajima A; Kadowaki T; Kubota N; Terauchi Y; Ishii G; Ochiai A; Esumi H; Kaminishi M
Cancer Res; 2005 Jun; 65(11):4769-74. PubMed ID: 15930296
[TBL] [Abstract][Full Text] [Related]
3. Ligands for peroxisome proliferator-activated receptors alpha and gamma inhibit chemically induced colitis and formation of aberrant crypt foci in rats.
Tanaka T; Kohno H; Yoshitani S; Takashima S; Okumura A; Murakami A; Hosokawa M
Cancer Res; 2001 Mar; 61(6):2424-8. PubMed ID: 11289109
[TBL] [Abstract][Full Text] [Related]
4. Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo.
Kubota T; Koshizuka K; Williamson EA; Asou H; Said JW; Holden S; Miyoshi I; Koeffler HP
Cancer Res; 1998 Aug; 58(15):3344-52. PubMed ID: 9699665
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor gamma ligands suppress liver carcinogenesis induced by diethylnitrosamine in rats.
Guo YT; Leng XS; Li T; Zhao JM; Lin XH
World J Gastroenterol; 2004 Dec; 10(23):3419-23. PubMed ID: 15526359
[TBL] [Abstract][Full Text] [Related]
6. Troglitazone, a ligand for peroxisome proliferator-activated receptor gamma, inhibits chemically-induced aberrant crypt foci in rats.
Kohno H; Yoshitani S; Takashima S; Okumura A; Hosokawa M; Yamaguchi N; Tanaka T
Jpn J Cancer Res; 2001 Apr; 92(4):396-403. PubMed ID: 11346461
[TBL] [Abstract][Full Text] [Related]
7. The effect of PPARgamma ligands on UV- or chemically-induced carcinogenesis in mouse skin.
He G; Muga S; Thuillier P; Lubet RA; Fischer SM
Mol Carcinog; 2005 Aug; 43(4):198-206. PubMed ID: 15864802
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines.
Yoshizawa K; Cioca DP; Kawa S; Tanaka E; Kiyosawa K
Cancer; 2002 Nov; 95(10):2243-51. PubMed ID: 12412180
[TBL] [Abstract][Full Text] [Related]
9. Protective role of luteolin on the status of lipid peroxidation and antioxidant defense against azoxymethane-induced experimental colon carcinogenesis.
Ashokkumar P; Sudhandiran G
Biomed Pharmacother; 2008 Nov; 62(9):590-7. PubMed ID: 18692983
[TBL] [Abstract][Full Text] [Related]
10. Induction mechanism of apoptosis by troglitazone through peroxisome proliferator-activated receptor-gamma in gastric carcinoma cells.
Yoshida K; Tanabe K; Fujii D; Oue N; Yasui W; Toge T
Anticancer Res; 2003; 23(1A):267-73. PubMed ID: 12680223
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the growth arrest and DNA damage-inducible gene 45 (GADD45) by peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells.
Bruemmer D; Yin F; Liu J; Berger JP; Sakai T; Blaschke F; Fleck E; Van Herle AJ; Forman BM; Law RE
Circ Res; 2003 Aug; 93(4):e38-47. PubMed ID: 12881480
[TBL] [Abstract][Full Text] [Related]
12. Differentiation and reversal of malignant changes in colon cancer through PPARgamma.
Sarraf P; Mueller E; Jones D; King FJ; DeAngelo DJ; Partridge JB; Holden SA; Chen LB; Singer S; Fletcher C; Spiegelman BM
Nat Med; 1998 Sep; 4(9):1046-52. PubMed ID: 9734398
[TBL] [Abstract][Full Text] [Related]
13. Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo.
Yu J; Qiao L; Zimmermann L; Ebert MP; Zhang H; Lin W; Röcken C; Malfertheiner P; Farrell GC
Hepatology; 2006 Jan; 43(1):134-43. PubMed ID: 16374840
[TBL] [Abstract][Full Text] [Related]
14. Activators of the nuclear receptor PPARgamma enhance colon polyp formation.
Saez E; Tontonoz P; Nelson MC; Alvarez JG; Ming UT; Baird SM; Thomazy VA; Evans RM
Nat Med; 1998 Sep; 4(9):1058-61. PubMed ID: 9734400
[TBL] [Abstract][Full Text] [Related]
15. Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis.
Mutoh M; Watanabe K; Kitamura T; Shoji Y; Takahashi M; Kawamori T; Tani K; Kobayashi M; Maruyama T; Kobayashi K; Ohuchida S; Sugimoto Y; Narumiya S; Sugimura T; Wakabayashi K
Cancer Res; 2002 Jan; 62(1):28-32. PubMed ID: 11782353
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of Embelin on colon carcinogenesis.
Dai Y; Qiao L; Chan KW; Yang M; Ye J; Ma J; Zou B; Gu Q; Wang J; Pang R; Lan HY; Wong BC
Cancer Res; 2009 Jun; 69(11):4776-83. PubMed ID: 19458067
[TBL] [Abstract][Full Text] [Related]
17. Primary culture model of peroxisome proliferator-activated receptor gamma activity in prostate cancer cells.
Xu Y; Iyengar S; Roberts RL; Shappell SB; Peehl DM
J Cell Physiol; 2003 Jul; 196(1):131-43. PubMed ID: 12767049
[TBL] [Abstract][Full Text] [Related]
18. The ligands of peroxisome proliferator-activated receptor (PPAR) gamma inhibit growth of human esophageal carcinoma cells through induction of apoptosis and cell cycle arrest.
Fujii D; Yoshida K; Tanabe K; Hihara J; Toge T
Anticancer Res; 2004; 24(3a):1409-16. PubMed ID: 15274302
[TBL] [Abstract][Full Text] [Related]
19. Effects of adlay on azoxymethane-induced colon carcinogenesis in rats.
Shih CK; Chiang W; Kuo ML
Food Chem Toxicol; 2004 Aug; 42(8):1339-47. PubMed ID: 15207385
[TBL] [Abstract][Full Text] [Related]
20. Troglitazone induces expression of PPARgamma in liver.
Davies GF; Khandelwal RL; Roesler WJ
Mol Cell Biol Res Commun; 1999; 2(3):202-8. PubMed ID: 10662598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
